ASX:OIL

2 stories mentioning ASX:OILUpdated 13m ago

Every FINWIRES story that references ASX:OIL, newest first.

Optiscan Imaging to Commence US Clinical Study for InVue, InForm Devices in Breast Conserving Surgery, Shares Up 7%

Optiscan Imaging (ASX:OIL) is set to start a US clinical study assessing the safety, performance and workflow utility of its InVue precision surgery imaging device and InForm digital pathology imaging device in patients undergoing breast-conserving surgery, according to a Wednesday Australian bourse filing.The company said the study will evaluate InVue for in vivo surgical imaging and InForm for ex vivo digital pathology imaging in 35 US patients, seeking to validate an integrated surgical-pathology workflow for US market entry and broader clinical expansion.The company's shares rose 7% in recent Wednesday trade.

ASX:OIL

Asia48d ago

Optiscan Imaging Says Half of Target Patients Imaged in Human Breast Cancer Imaging Study

Optiscan Imaging (ASX:OIL) said 25 of the target 50 patients were imaged in its first in-human breast cancer imaging study at Royal Melbourne Hospital in Victoria, reaching a halfway mark milestone, according to a Thursday Australian bourse filing.The study is assessing surgical margins in breast cancer patients undergoing lumpectomy procedures using the InVue precision surgery imaging device for in vivo imaging and the InForm digital pathology imaging device for ex vivo imaging, per the filing.InVue is used intraoperatively in the resection cavity to generate live in vivo images immediately after tumor removal, while InForm is used to analyze the excised tissue.Clinical readouts of the analyzed cases to date show nine with clear margins, four with narrowly clear margins, and five with involved margins, the company said. There were no reported adverse events related to intravenous sodium fluorescein contrast agent injections.The study was expanded to a second clinical site to accelerate recruitment.

ASX:OIL

Track with the FINWIRES app suite

FolioX

Track ASX:OIL in your portfolio

WheelAI

Analyze ASX:OIL options with the wheel strategy

StockInsider

See market sentiment on ASX:OIL